Taysha Gene Therapies, Inc. - COM SHS (TSHA)

Historical Portfolio Holders from Q3 2020 to Q1 2024

All holders as of March 31, 2024
Q1 2024
Type / Class
Equity / COM SHS
Shares, excl. options Q1 2024
135 M
Holdings value Q1 2024
$387 M
Value change Q1 2024
+$19.2 M
Grand Portfolio weight change Q1 2024
+0%
Number of holders
103
Number of buys Q1 2024
61
Number of sells Q1 2024
-41
Average buys Q1 2024 %
+0.001%
Average sells Q1 2024 %
-0.001%
CUSIP
877619106
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q1 135 M $387 M +$19.2 M $2.87 103
2023 Q4 130 M $230 M -$12.4 M $1.77 84
2023 Q3 130 M $410 M +$376 M $3.16 61
2023 Q2 13.7 M $9.05 M -$2.01 M $0.66 37
2023 Q1 16.7 M $13.3 M -$3.03 M $0.80 42
2022 Q4 19.4 M $43.8 M +$11.9 M $2.26 51
2022 Q3 12.9 M $25 M -$1.79 M $1.93 47
2022 Q2 14.6 M $54.4 M -$11.1 M $3.72 53
2022 Q1 16.8 M $110 M -$16.4 M $6.52 68
2021 Q4 18.3 M $213 M -$15.5 M $11.65 60
2021 Q3 19.4 M $362 M +$2.74 M $18.62 48
2021 Q2 18.3 M $388 M +$15 M $21.20 48
2021 Q1 17.7 M $359 M -$11.6 M $20.30 46
2020 Q4 16.9 M $447 M +$34.1 M $26.54 49
2020 Q3 16.6 M $367 M +$367 M $22.40 46